EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Caregiving and Racial Considerations During a Pandemic Online Training Education

Not Applicable

Completed

Conditions: Caregiver Stress Syndrome

Interventions: Behavioral: CaRE Course

First Posted Date: 2021-02-01

Last Posted Date: 2022-11-10

Lead Sponsor: Emory University

Target Recruit Count: 75

Registration Number: NCT04732715

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Pilocarpine Microneedles for Sweat Induction (PMN-SI)

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Device: Pilocarpine microneedle patch
Device: Pilocarpine Iontophoresis

First Posted Date: 2021-02-01

Last Posted Date: 2023-05-22

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT04732195

Locations: 🇺🇸
Children's Healthcare of Atlanta - Egleston Hospital, Atlanta, Georgia, United States

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Phase 1

Recruiting

Conditions: Malignant Urinary System Neoplasm
Hypogonadism
Urinary System Disorder
Urinary System Neoplasm

Interventions: Other: Best Practice
Procedure: Quality-of-Life Assessment
Drug: Testosterone Cypionate
Other: Questionnaire Administration

First Posted Date: 2021-02-01

Last Posted Date: 2024-12-27

Lead Sponsor: Emory University

Target Recruit Count: 100

Registration Number: NCT04731376

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Telederm and Bullous Pemphigoid

Completed

Conditions: Bullous Pemphigoid

First Posted Date: 2021-01-28

Last Posted Date: 2023-10-13

Lead Sponsor: Emory University

Target Recruit Count: 21

Registration Number: NCT04728854

Locations: 🇺🇸
Emory Dermatology Clinic, Atlanta, Georgia, United States

Proton Radiation Therapy for the Treatment of Patients with High Risk Prostate Cancer

Not Applicable

Recruiting

Conditions: Stage III Prostate Cancer AJCC V8
Stage IIIA Prostate Cancer AJCC V8
Stage IIIB Prostate Cancer AJCC V8
Stage IIIC Prostate Cancer AJCC V8

Interventions: Radiation: High-Dose Rate Brachytherapy
Radiation: Proton Beam Radiation Therapy
Other: Quality-of-Life Assessment
Other: Survey Administration

First Posted Date: 2021-01-27

Last Posted Date: 2024-11-14

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT04725903

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

DTA (Dopaminergic Therapy for Anhedonia) Study

Phase 4

Completed

Conditions: Depression
Anhedonia

Interventions: Drug: Carbidopa Levodopa
Drug: Placebo

First Posted Date: 2021-01-25

Last Posted Date: 2024-12-16

Lead Sponsor: Emory University

Target Recruit Count: 19

Registration Number: NCT04723147

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Device: The Omnipod 5/Horizon HCL system

First Posted Date: 2021-01-19

Last Posted Date: 2024-04-23

Lead Sponsor: Emory University

Target Recruit Count: 22

Registration Number: NCT04714216

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Grady Health System (non-CRN), Atlanta, Georgia, United States
🇺🇸
University of Virginia School of Medicine, Charlottesville, Virginia, United States

Electrophysiological Biomarkers in MTLE Patients.

Not Applicable

Terminated

Conditions: Mesial Temporal Lobe Epilepsy

Interventions: Device: Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device

First Posted Date: 2021-01-14

Last Posted Date: 2024-03-05

Lead Sponsor: Emory University

Target Recruit Count: 1

Registration Number: NCT04710004

Locations: 🇺🇸
Epilepsy monitoring unit (EMU) at Emory University Hospital, Atlanta, Georgia, United States

Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides

Phase 1

Terminated

Conditions: Mycosis Fungoides
Sezary Syndrome
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

Interventions: Procedure: Extracorporeal Photopheresis
Biological: Mogamulizumab
Other: Quality-of-Life Assessment

First Posted Date: 2020-12-19

Last Posted Date: 2024-08-13

Lead Sponsor: Emory University

Target Recruit Count: 5

Registration Number: NCT04676087

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Mechanistic Interventions and Neuroscience of Dissociation

Not Applicable

Recruiting

Conditions: Dissociation

Interventions: Behavioral: Breath Focus
Behavioral: No Distractions
Device: Vibration

First Posted Date: 2020-12-17

Last Posted Date: 2024-02-15

Lead Sponsor: Emory University

Target Recruit Count: 200

Registration Number: NCT04670640

Locations: 🇺🇸
Grady Hospital, Atlanta, Georgia, United States
🇺🇸
Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy